摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2,6-tBu2-4-MeC6H2O)3Y(THF)2 | 1280214-95-0

中文名称
——
中文别名
——
英文名称
(2,6-tBu2-4-MeC6H2O)3Y(THF)2
英文别名
[Y(OC6H2-4-Me-2,6-(t-Bu)2)3(THF)2]
(2,6-tBu2-4-MeC6H2O)3Y(THF)2化学式
CAS
1280214-95-0
化学式
C53H85O5Y
mdl
——
分子量
891.161
InChiKey
MNQZEDRXTMOHSH-UHFFFAOYSA-K
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Activation of Carbodiimide and Transformation with Amine to Guanidinate Group by Ln(OAr)3(THF)2 (Ln: Lanthanide and Yttrium) and Ln(OAr)3(THF)2 as a Novel Precatalyst for Addition of Amines to Carbodiimides: Influence of Aryloxide Group
    摘要:
    Reaction of Ln(OAr1)(3)(THF)(2) (Ar-1 = [2,6-(Bu-t)(2)-4-MeC6H2] with carbodiimides (RNCNR) in toluene afforded the RNCNR coordinated complexes ((ArO)-O-1)(3)Ln(NCNR) (R = Pr-i (isopropyl), Ln = Y (1) and Yb (2); R = Cy (cyclohexyl), Ln = Y (3)) in high yields. Treatment of 1 and 2, with 4-chloroaniline, respectively, at a molar ratio of 1:1 yielded the corresponding monoguanidinate complex ((ArO)-O-1)(2)Y[(4-Cl-C6H4N)C((NHPr)-Pr-i) (NPr)-Pr-i](THF) (4) and ((ArO)-O-1)(2)Yb[(4-Cl-C6H4N)C((NHPr)-Pr-i)(NPr)-Pr-i] (THF) (5). Complexes 4 and 5 can be prepared by the reaction of Ln(OAr1)(3)(THF)(2) with RNCNR and amine in toluene at a 1:1:1 molar ratio in high yield directly. A remarkable influence of the aryloxide ligand on this transformation was observed. The similar transformation using the less bulky yttrium complexes Y(OAr2)(3)(THF)(2) (Ar-2 = [2,6-(Pr-i)(2)C6H3]) or Y(OAr3)(3)(THF)(2) (Ar-3 = [2,6-Me2C6H3]) did not occur. Complexes Ln(OAr1)(3)(THF)(2) were found to be the novel precatalysts for addition of RNCNR with amines, which represents the first example of catalytic guanylation by the lanthanide complexes with the Ln-O active group. The catalytic activity of Y(OAr1)(3)(THF)(2) was found to be the same as that of monoguanidinate complex 4, indicating 4 is one of the active intermediates in the present process. The other intermediate, amide complex ((ArO)-O-1)(2)Ln[(2-OCH3-C6H4NH)(2-OCH3-C6H4NH2)] (6), was isolated by protonolysis of 4 with 2-OCH3-C6H4NH2. All the complexes were structurally characterized by X-ray single crystal determination.
    DOI:
    10.1021/ic200091s
  • 作为产物:
    参考文献:
    名称:
    Activation of Carbodiimide and Transformation with Amine to Guanidinate Group by Ln(OAr)3(THF)2 (Ln: Lanthanide and Yttrium) and Ln(OAr)3(THF)2 as a Novel Precatalyst for Addition of Amines to Carbodiimides: Influence of Aryloxide Group
    摘要:
    Reaction of Ln(OAr1)(3)(THF)(2) (Ar-1 = [2,6-(Bu-t)(2)-4-MeC6H2] with carbodiimides (RNCNR) in toluene afforded the RNCNR coordinated complexes ((ArO)-O-1)(3)Ln(NCNR) (R = Pr-i (isopropyl), Ln = Y (1) and Yb (2); R = Cy (cyclohexyl), Ln = Y (3)) in high yields. Treatment of 1 and 2, with 4-chloroaniline, respectively, at a molar ratio of 1:1 yielded the corresponding monoguanidinate complex ((ArO)-O-1)(2)Y[(4-Cl-C6H4N)C((NHPr)-Pr-i) (NPr)-Pr-i](THF) (4) and ((ArO)-O-1)(2)Yb[(4-Cl-C6H4N)C((NHPr)-Pr-i)(NPr)-Pr-i] (THF) (5). Complexes 4 and 5 can be prepared by the reaction of Ln(OAr1)(3)(THF)(2) with RNCNR and amine in toluene at a 1:1:1 molar ratio in high yield directly. A remarkable influence of the aryloxide ligand on this transformation was observed. The similar transformation using the less bulky yttrium complexes Y(OAr2)(3)(THF)(2) (Ar-2 = [2,6-(Pr-i)(2)C6H3]) or Y(OAr3)(3)(THF)(2) (Ar-3 = [2,6-Me2C6H3]) did not occur. Complexes Ln(OAr1)(3)(THF)(2) were found to be the novel precatalysts for addition of RNCNR with amines, which represents the first example of catalytic guanylation by the lanthanide complexes with the Ln-O active group. The catalytic activity of Y(OAr1)(3)(THF)(2) was found to be the same as that of monoguanidinate complex 4, indicating 4 is one of the active intermediates in the present process. The other intermediate, amide complex ((ArO)-O-1)(2)Ln[(2-OCH3-C6H4NH)(2-OCH3-C6H4NH2)] (6), was isolated by protonolysis of 4 with 2-OCH3-C6H4NH2. All the complexes were structurally characterized by X-ray single crystal determination.
    DOI:
    10.1021/ic200091s
  • 作为试剂:
    描述:
    邻氯苯胺N,N'-二环己基碳二亚胺(2,6-tBu2-4-MeC6H2O)3Y(THF)2 作用下, 反应 2.0h, 以95%的产率得到2-(2-chlorophenyl)-1,3-dicyclohexylguanidine
    参考文献:
    名称:
    Activation of Carbodiimide and Transformation with Amine to Guanidinate Group by Ln(OAr)3(THF)2 (Ln: Lanthanide and Yttrium) and Ln(OAr)3(THF)2 as a Novel Precatalyst for Addition of Amines to Carbodiimides: Influence of Aryloxide Group
    摘要:
    Reaction of Ln(OAr1)(3)(THF)(2) (Ar-1 = [2,6-(Bu-t)(2)-4-MeC6H2] with carbodiimides (RNCNR) in toluene afforded the RNCNR coordinated complexes ((ArO)-O-1)(3)Ln(NCNR) (R = Pr-i (isopropyl), Ln = Y (1) and Yb (2); R = Cy (cyclohexyl), Ln = Y (3)) in high yields. Treatment of 1 and 2, with 4-chloroaniline, respectively, at a molar ratio of 1:1 yielded the corresponding monoguanidinate complex ((ArO)-O-1)(2)Y[(4-Cl-C6H4N)C((NHPr)-Pr-i) (NPr)-Pr-i](THF) (4) and ((ArO)-O-1)(2)Yb[(4-Cl-C6H4N)C((NHPr)-Pr-i)(NPr)-Pr-i] (THF) (5). Complexes 4 and 5 can be prepared by the reaction of Ln(OAr1)(3)(THF)(2) with RNCNR and amine in toluene at a 1:1:1 molar ratio in high yield directly. A remarkable influence of the aryloxide ligand on this transformation was observed. The similar transformation using the less bulky yttrium complexes Y(OAr2)(3)(THF)(2) (Ar-2 = [2,6-(Pr-i)(2)C6H3]) or Y(OAr3)(3)(THF)(2) (Ar-3 = [2,6-Me2C6H3]) did not occur. Complexes Ln(OAr1)(3)(THF)(2) were found to be the novel precatalysts for addition of RNCNR with amines, which represents the first example of catalytic guanylation by the lanthanide complexes with the Ln-O active group. The catalytic activity of Y(OAr1)(3)(THF)(2) was found to be the same as that of monoguanidinate complex 4, indicating 4 is one of the active intermediates in the present process. The other intermediate, amide complex ((ArO)-O-1)(2)Ln[(2-OCH3-C6H4NH)(2-OCH3-C6H4NH2)] (6), was isolated by protonolysis of 4 with 2-OCH3-C6H4NH2. All the complexes were structurally characterized by X-ray single crystal determination.
    DOI:
    10.1021/ic200091s
点击查看最新优质反应信息

文献信息

  • Phenylene-bridged β-Ketoiminate Dilanthanide Aryloxides: Synthesis, Structure, and Catalytic Activity for Addition of Amines to Carbodiimides
    作者:Yubiao Hong、Yu Zheng、Mingqiang Xue、Yingming Yao、Yong Zhang、Qi Shen
    DOI:10.1002/zaac.201500047
    日期:2015.6
    tetrahydrofuran) in a 1:2 molar ratio in THF, after workup, to give the corresponding dilanthanide aryloxides L[Ln(OAr)2(THF)]2 [Ln = Yb (2), Y (3), Sm (4), Nd (5), La (6)] in high isolated yields. Compound 1 and complexes 2–6 were fully characterized, including X-ray crystal structure analyses for complexes 2, 3, 5, and 6. Complexes 2–6 can be used as efficient pre-catalysts for catalytic addition of amines
    介绍了一系列由对亚苯基桥连的双(β-酮亚胺酸)配体稳定的双系元素芳基氧化物的合成和反应性。1,4-二基苯与乙酰丙酮以1:2.5摩尔比在无乙醇中反应以高产率得到化合物1,4-双(4-亚基-2-戊酮)苯(1)(LH2)。化合物 1 与 (ArO)3Ln(THF)2(ArO = 2,6-tBu2-4-MeC6H2O,THF = 四氢呋喃)在 THF 中以 1:2 的摩尔比反应,后处理,得到相应的二系芳基氧化物 L[ Ln(OAr)2(THF)]2 [Ln = Yb (2), Y (3), Sm (4), Nd (5), La (6)] 分离率高。化合物 1 和配合物 2-6 得到了充分表征,包括对配合物 2、3、5 和 6 的 X 射线晶体结构分析。配合物 2-6 可用作将胺催化加成到碳二亚胺的有效预催化剂,随着La (6) < Nd (5) ≈ Sm (4) < Y (3) ≈ Yb
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫